HOME >> MEDICINE >> NEWS
Heart transplant survival: Results may be key to rejection prevention, detection, treatment

Research to be presented at the International Society for Heart and Lung Transplantation (ISHLT) 24th Annual Meeting April 21-24 in San Francisco, points to major victories in the battle for immune system balance in heart transplant patients.

"The combination of emerging technologies and drugs could mean greatly improved patient management and longer survival rates," said Mandeep Mehra, M.D., Program Chair of ISHLT and an ISHLT director. "The results of these studies have been much anticipated by the transplant community."

Some of the late-breaking trial results to be revealed include:

  • Use of intravascular ultrasound as a predictor for long-term heart transplant outcomes Data from a five-year multi-center validation study (Abstract #27)
  • Immunosuppressant drug everolimus used to prevent acute cardiac disease and rejection 24-month study results (Abstract #28)
  • Using molecular testing to predict clinical outcomes for heart transplantation Outcomes of a prospective multi-center trial (Abstract #192)
  • Protection from transplant disease (graft vasculopathy) with use of sirolimus from time of heart transplantation Results from a two-year study (Abstract #193)

Worldwide, approximately 4,500 cardiac transplants are performed annually. Despite significant progress made in surgical techniques and post-operative care, the risks associated with cardiac surgery remain high. The one-year survival rate after transplantation is approximately 80 percent; this number drops to nearly 50 percent after 10 years. The leading cause of death during the first three years is acute rejection of the transplanted organ. The patient's immune system attacks the heart as if it were a foreign object until it no longer functions properly.

Another contributing factor to limited survival rates is cardiac allograft vasculopathy (transplant vessel damage). This thickening of artery walls in a transplanted heart
'"/>

Contact: Kelly Goff
kellygoff@server63.com
210-378-1980
International Society for Heart and Lung Transplantation
19-Apr-2004


Page: 1 2

Related medicine news :

1. The European Society of Cardiology launches Women at Heart
2. Heart surgeons publish death rates
3. Heart attack treatment gap may be closing for women
4. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
5. Brenner Childrens Hospital named to NIH Pediatric Heart Network
6. Heart patients treated by non-cardiologists less likely to receive medications
7. Heart failure patients treated for diabetes with insulin have increase in mortality
8. New research results: Heart jacket shown to be effective
9. Heart surgery patients receive less aggressive discharge care
10. Heart attack, stroke risk overlooked in diabetics
11. Heart arrhythmias easily treated, yet few know risks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... December 02, 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a ... No other wearable health technology on the market can deliver all that rejiva can. ... meaningful insights about their health than the usual heart rate and steps taken”, adds ...
(Date:12/2/2016)... ... 02, 2016 , ... On November 24th, 2016, Thanksgiving morning, ... different sites throughout Miami-Dade and Broward counties. This is the largest meal delivery ... Thanksgiving morning by putting together individual meals via assembly lines and passing them ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... that we have been designated as a Cigna Infertility Center of Excellence. The ... performance standards. , “It’s an honor to be designated a Cigna Infertility ...
(Date:11/30/2016)... Gardens, FL (PRWEB) , ... November 30, 2016 ... ... eating disorder and mental health treatment has announced the opening of a new ... specialized partial hospitalization and intensive outpatient treatment for adults and adolescents, both males ...
(Date:11/30/2016)... Austin, TX (PRWEB) , ... November 30, 2016 ... ... like to remind the clinical research community that the FDA Binding Guidance goes ... submit data in FDA-supported formats listed in the FDA Data Standards Catalog. The ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2, 2016 On Thursday, December ... excellence in research, development and innovation in the biopharmaceutical ... was held in the presence of Sergey Tsyb, Vice ... Russian Federation , Natalia Sanina, First Vice Chairman ... , Head of Roszdravnadzor, National Service of Control in ...
(Date:12/2/2016)... Dec. 2, 2016 CVS Health Corporation (NYSE: ... Day in New York City on Thursday, December 15, 2016, beginning at 8:00 ... team will provide an in-depth review of the company,s ... The company will also discuss 2017 earnings guidance during ... of the event will be broadcast simultaneously on the ...
(Date:12/2/2016)... YORK , December 2, 2016 ... the trading session in red, while the Dow Jones Industrial ... at the close of US markets, which prompted Stock-callers this ... stocks: NuVasive Inc. (NASDAQ: NUVA ), Smith & ... (NASDAQ: NXTM ), and Cesca Therapeutics Inc. (NASDAQ: ...
Breaking Medicine Technology:
Cached News: